Financhill
Back

Contineum Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

CTNM
Contineum Therapeutics, Inc.

Last Price:
$12.34
Seasonality Move:
-24.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Contineum Therapeutics, Inc. Stock Forecast

  • Is Contineum Therapeutics, Inc. Stock Undervalued?
    The current Contineum Therapeutics, Inc. [CTNM] share price is $12.26. The Score for CTNM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • CTNM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Contineum Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Contineum Therapeutics, Inc. Stock Rating

Data Unavailable

Contineum Therapeutics, Inc. Stock Price History

Is CTNM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTNM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contineum-tx.com

52-Week Data

52-Week High:
15.25
52-Week Low:
3.35

Prediction Charts

Market Cap:
317.2M
Price in USD:
12.26
Volume:
139.5K
Beta:
1.10

Technical Analysis

SMA50:
11.32
SMA100:
10.73
SMA200:
7.80
52-Wk Change:
-9.19%

Stock Predictions

  • Is Contineum Therapeutics, Inc. stock public?
    Yes, Contineum Therapeutics, Inc. is a publicly traded company.
  • What is the Contineum Therapeutics, Inc. stock quote today?
    The Contineum Therapeutics, Inc. stock price is 12.26 USD today.
  • How to buy Contineum Therapeutics, Inc. stock online?
    You can buy Contineum Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 10.53 11.12 11.15 10.46
Dec-4 11.08 10.98 11.43 10.86
Dec-5 11.02 11.04 11.05 10.89
Dec-8 11.04 12.25 12.34 11.04
Dec-9 12.26 12.50 13.00 12.05
Dec-10 12.50 12.52 12.80 12.11
Dec-11 12.60 13.07 13.48 12.41
Dec-12 12.33 11.63 12.65 11.50
Dec-15 11.61 11.58 11.85 11.58
Dec-16 11.52 11.55 11.77 11.50
Dec-17 11.62 11.48 12.00 11.48
Dec-18 11.49 11.39 11.75 11.38
Dec-19 11.32 11.74 11.88 11.27
Dec-22 11.74 12.26 12.41 11.74

Contineum Therapeutics, Inc. Earnings

Data Unavailable

Contineum Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.19 per share.

* Contineum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.